AAPL 171.24 +2.63 (+1.56%)MSFT 110.63 +1.88 (+1.73%)FB 146.64 +4.56 (+3.21%)ZNGA 3.8 +0.15 (+3.97%)NVDA 152.46 +4.29 (+2.89%)WBA 83.03 +1.21 (+1.48%)GOOG 1080.15 +28.57 (+2.72%)PIH 5 -0.12 (-2.34%)
AAPL 171.24 +2.63 (+1.56%)MSFT 110.63 +1.88 (+1.73%)FB 146.64 +4.56 (+3.21%)ZNGA 3.8 +0.15 (+3.97%)NVDA 152.46 +4.29 (+2.89%)WBA 83.03 +1.21 (+1.48%)GOOG 1080.15 +28.57 (+2.72%)PIH 5 -0.12 (-2.34%)

Company Profile ABLX Quote Ablynx NV

Ablynx NV Quote

Ablynx NV (ABLX)

52.78 -0.02 Healthcare

CEO

Edwin Moses

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Ablynx NV is a clinical-stage biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.